| |
| Issue |
Title |
| |
| No 20 (2021) |
Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitors |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar |
| |
| No 20 (2021) |
Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma |
Abstract
PDF (Rus)
|
|
E. Yu. Antonova, E. A. Moroz, D. V. Podluzhny, N. E. Kudashkin, I. A. Dzhanyan, A. Yu. Volkov, K. K. Laktionov, V. V. Breder |
| |
| No 20 (2021) |
Cholangiocarcinogenesis and targeted therapy for cholangiocarcinoma |
Abstract
PDF (Rus)
|
|
A. A. Gritskevich, B. N. Gurmikov, T. P. Baitman, A. N. Shipilova, A. A. Paichadze, A. V. Chzhao |
| |
| No 20 (2021) |
Neoadjuvant therapy bridging patients with hepatocellular cancer waiting for liver transplant |
Abstract
PDF (Rus)
|
|
A. A. Pitkevich, V. Yu. Kosyrev, I. A. Dzhanyan, M. S. Novruzbekov, A. R. Monakhov, S. I. Zubenko, S. E. Voskanyan, V. S. Rudakov, E. A. Moroz, V. V. Breder |
| |
| 1 - 4 of 4 Items |
|
